53041 | 53041 | CSPPT- Chronic Kidney Diseases Study | Active, not recruiting | No Results Available | Hypertension|Hyperhomocysteinemia | Drug: Enalapril maleate and folic acid tablets|Drug: Enalapril maleate | https://ClinicalTrials.gov/show/NCT01871740 |
53042 | 53042 | A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma | Active, not recruiting | No Results Available | Persistent or Recurrent Cutaneous T-Cell Lymphoma | Drug: E7777 | https://ClinicalTrials.gov/show/NCT01871727 |
53043 | 53043 | Phenotypic Properties in Individuals Affected With XLHED | Completed | No Results Available | X Linked Hypohidrotic Ectodermal Dysplasia | | https://ClinicalTrials.gov/show/NCT01871714 |
53044 | 53044 | Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs | Completed | No Results Available | Healthy | Drug: Escitalopram|Drug: Quetiapine|Drug: Moxifloxacin|Other: Placebo | https://ClinicalTrials.gov/show/NCT01871701 |
53045 | 53045 | Pelvic Floor Rehabilitation for Gynecological Cancer Patients | Recruiting | No Results Available | Malignant Female Reproductive System Neoplasm | Behavioral: pelvic floor rehabilitation program with neuromodulation | https://ClinicalTrials.gov/show/NCT01871688 |
53046 | 53046 | Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies | Recruiting | No Results Available | Lymphoma|Chronic Lymphocytic Leukemia|Non-Hodgkin Lymphoma|T-cell Lymphoma | Drug: IPI-145|Drug: Rituximab|Drug: Bendamustine | https://ClinicalTrials.gov/show/NCT01871675 |
53047 | 53047 | Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C | Withdrawn | No Results Available | Hepatitis C, Chronic | Drug: Legalon® SIL (Silibinin)|Drug: Pegylated interferon alfa2b|Drug: Ribavirin | https://ClinicalTrials.gov/show/NCT01871662 |
53048 | 53048 | Initial Treatment With Golimumab in Early PsA | Recruiting | No Results Available | Psoriatic Arthritis | Drug: golimumab|Drug: methotrexate | https://ClinicalTrials.gov/show/NCT01871649 |
53049 | 53049 | ESD Versus EMR for Treatment of Early Barrett`s Adenocarcinoma | Completed | No Results Available | High Grade Intraepithelial Neoplasia|Barrett Adenocarcinoma | Procedure: Endoscopic mucosal resection|Procedure: Waterjet-assisted ESD|Device: HybridKnife | https://ClinicalTrials.gov/show/NCT01871636 |
53050 | 53050 | One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I Osteotomy | Recruiting | No Results Available | Cleft Lip and Palate|Le Fort | Procedure: Segmental Le Fort I osteotomy|Procedure: One-piece Le Fort I Osteotomy | https://ClinicalTrials.gov/show/NCT01871623 |
53051 | 53051 | Amyloid Accumulation After Mild Traumatic Brain Injury | Enrolling by invitation | No Results Available | Traumatic Brain Injury | Drug: [18F]AV-45 PET amyloid binding imaging | https://ClinicalTrials.gov/show/NCT01871610 |
53052 | 53052 | Pulmonary Artery Energy Sealing for VATS Procedure | Completed | No Results Available | Lung Cancer | Device: Pulmonary Artery Energy Seal | https://ClinicalTrials.gov/show/NCT01871597 |
53053 | 53053 | A Post Marketing Study of Angel of Waterâ„¢ for Colon Cleansing as Preparation for Colonoscopy | Recruiting | No Results Available | Colon Diseases | Device: Colon cleansing by hydrotherapy | https://ClinicalTrials.gov/show/NCT01871584 |
53054 | 53054 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | Recruiting | No Results Available | Mucinous Adenocarcinoma of the Rectum|Signet Ring Adenocarcinoma of the Rectum|Stage IIA Rectal Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage IIIA Rectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Rectal Cancer | Biological: bevacizumab|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracil|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT01871571 |
53055 | 53055 | Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin | Recruiting | No Results Available | Type 2 Diabetes Mellitus (T2DM) | Drug: Vildagliptin|Drug: Metformin|Drug: sulfonylurea (SU)|Drug: Basal Insulin | https://ClinicalTrials.gov/show/NCT01871558 |
53056 | 53056 | Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) | Recruiting | No Results Available | Hepatocellular Carcinoma|HCC | Device: Magnetic Resonance Imaging | https://ClinicalTrials.gov/show/NCT01871545 |
53057 | 53057 | Low-dose Gonal-f® in Ovulation Induction | Completed | No Results Available | Infertility|Monofollicular Development | Drug: Gonal-f® | https://ClinicalTrials.gov/show/NCT01871532 |
53058 | 53058 | Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs | Active, not recruiting | No Results Available | Compression Fracture of Vertebral Body|Osteoporosis|Cancer. | Device: Balloon kyphoplasty | https://ClinicalTrials.gov/show/NCT01871519 |
53059 | 53059 | Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial | Recruiting | No Results Available | Smoking Cessation | Behavioral: Standard Care (SC)|Behavioral: Intensive Counseling (IC) | https://ClinicalTrials.gov/show/NCT01871506 |
53060 | 53060 | A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants | Completed | No Results Available | Healthy Volunteers | Drug: LY2605541|Drug: Insulin Lispro | https://ClinicalTrials.gov/show/NCT01871493 |
53061 | 53061 | CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer | Terminated | No Results Available | Non-Small Cell Lung Cancer | Drug: Group A:cytokine-induced killer cell +gefitinib|Drug: Group B:Gefitinib | https://ClinicalTrials.gov/show/NCT01871480 |
53062 | 53062 | Sargramostim for Myeloid Dendritic Cell Deficiency | Completed | No Results Available | Dendritic Cell Deficiency | Drug: Sargramostim | https://ClinicalTrials.gov/show/NCT01871467 |
53063 | 53063 | Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers | Recruiting | No Results Available | Non-small Cell Lung Cancers | Procedure: stereotactic ablative radiotherapy (SABR)|Drug: Pentoxifylline | https://ClinicalTrials.gov/show/NCT01871454 |
53064 | 53064 | Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies | Recruiting | No Results Available | Malignant Neoplasm | Radiation: Total-body irradiation|Biological: Donor lymphocytes infusion (DLI)|Drug: Cyclophosphamide|Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT)|Drug: Tacrolimus|Drug: Mycophenolate mofetil | https://ClinicalTrials.gov/show/NCT01871441 |
53065 | 53065 | A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy | Completed | No Results Available | Diabetes Mellitus, Type 2 | Drug: aleglitazar|Drug: placebo | https://ClinicalTrials.gov/show/NCT01871428 |
53066 | 53066 | A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy | Completed | No Results Available | Diabetes Mellitus, Type 2 | Drug: aleglitazar|Drug: metformin|Drug: placebo | https://ClinicalTrials.gov/show/NCT01871415 |
53067 | 53067 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) | Completed | No Results Available | Plaque Psoriasis | Drug: 000-0551 Lotion|Drug: Vehicle Lotion | https://ClinicalTrials.gov/show/NCT01871402 |
53068 | 53068 | Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects | Completed | No Results Available | Bariatric Surgery | | https://ClinicalTrials.gov/show/NCT01871389 |
53069 | 53069 | Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation | Active, not recruiting | No Results Available | Polypoidal Choroidal Vasculopathy | Drug: Intravitreal aflibercept injection 2.0mg | https://ClinicalTrials.gov/show/NCT01871376 |
53070 | 53070 | Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer | Recruiting | No Results Available | Locally Advanced Malignant Neoplasm | Radiation: chemoradiation | https://ClinicalTrials.gov/show/NCT01871363 |